Inventor · disambiguated record
Scott Hecker
Also filed as: HECKER SCOTT · HECKER SCOTT J
79 granted patents·21 pending applications·970 citations·filing 1993–2024
99Inventor score
Files withREMPEX PHARMACEUTICALS INC22MICROCIDE PHARMACEUTICALS INC16QPEX BIOPHARMA INC12METABASIS THERAPEUTICS INC11MELINTA SUBSIDIARY CORP9
Top patents by PatentIndex Score
100 records- 0198US9101638B2Boronic acid derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Aug 11, 2015·54 cites·44 claims
- 0297US11180512B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2020·Granted Nov 23, 2021·4 cites·20 claims
- 0397US9694025B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·21 cites·14 claims
- 0496US11999759B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2021·Granted Jun 4, 2024·2 cites·21 claims
- 0596US10004758B2Cyclic boronic acid ester derivatives and methods of making the sameREMPEX PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·18 cites·30 claims
- 0696US9642869B2Boronic acid derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2014·Granted May 9, 2017·28 cites·48 claims
- 0796US9296763B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·27 cites·24 claims
- 0896US9241947B2Boronic acid derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Jan 26, 2016·22 cites·37 claims
- 0996US9156858B2Boronic acid derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Oct 13, 2015·24 cites·2 claims
- 1096US8680136B2Cyclic boronic acid ester derivatives and therapeutic uses thereofHIRST GAVIN·Filed 2011·Granted Mar 25, 2014·69 cites·27 claims
- 1195US11090319B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2020·Granted Aug 17, 2021·3 cites·9 claims
- 1295US10570159B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2019·Granted Feb 25, 2020·6 cites·26 claims
- 1395US9963467B2Boronic acid derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2015·Granted May 8, 2018·14 cites·31 claims
- 1495US9132140B2Boronic acid derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2014·Granted Sep 15, 2015·38 cites·26 claims
- 1595US9012491B2Heterocyclic boronic acid ester derivatives and therapeutic uses thereofREDDY RAJA K·Filed 2012·Granted Apr 21, 2015·27 cites·39 claims
- 1694US10618918B2Substituted boronic acids as antimicrobialsQPEX BIOPHARMA INC·Filed 2019·Granted Apr 14, 2020·6 cites·23 claims
- 1794US7041670B2Florfenicol-type antibioticsSCHERING PLOUGH ANIMAL HEALTH·Filed 2003·Granted May 9, 2006·40 cites·27 claims
- 1893US10639318B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·3 cites·21 claims
- 1993US10206937B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2015·Granted Feb 19, 2019·17 cites·43 claims
- 2093US10183034B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 22, 2019·7 cites·29 claims
- 2193US10172874B2Pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 8, 2019·7 cites·24 claims
- 2292US10662205B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2015·Granted May 26, 2020·6 cites·35 claims
- 2392US2025064838A1Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 2491US10294249B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2017·Granted May 21, 2019·8 cites·38 claims
- 2590US12161656B2Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2024·Granted Dec 10, 2024·0 cites·30 claims
- 2690US12016868B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2019·Granted Jun 25, 2024·3 cites·23 claims
- 2790US7361689B2Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereofSCHERING PLOUGH ANIMAL HEALTH·Filed 2004·Granted Apr 22, 2008·38 cites·13 claims
- 2890US2025049820A1Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 2988US12171772B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2023·Granted Dec 24, 2024·0 cites·5 claims
- 3087US12509475B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2024·Granted Dec 30, 2025·0 cites·20 claims
- 3187US9278105B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2012·Granted Mar 8, 2016·6 cites·60 claims
- 3287US8710236B2Antagonists of the glucagon receptorGOMEZ-GALENO JORGE E·Filed 2011·Granted Apr 29, 2014·10 cites·5 claims
- 3387US7153842B2Florfenicol prodrug having improved water solubilitySCHERING PLOUGH ANIMAL HEALTH·Filed 2004·Granted Dec 26, 2006·27 cites·30 claims
- 3486US9701626B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2015·Granted Jul 11, 2017·5 cites·10 claims
- 3586US9169201B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·8 cites·13 claims
- 3686US8962618B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofREDDY K RAJA·Filed 2012·Granted Feb 24, 2015·7 cites·6 claims
- 3786US8907103B2Glucagon antagonistsGOMEZ-GALENO JORGE E·Filed 2009·Granted Dec 9, 2014·10 cites·19 claims
- 3886US7713950B2Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereofINTERVET INC·Filed 2008·Granted May 11, 2010·8 cites·4 claims
- 3985US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 4085US8063025B2Nucleoside prodrugs and uses thereofHECKER SCOTT J·Filed 2008·Granted Nov 22, 2011·11 cites·18 claims
- 4185US6043238A2-Aminobenzazapine derivativesPFIZER·Filed 1997·Granted Mar 28, 2000·37 cites·5 claims
- 4284US7572777B2Florfenicol prodrug having improved water solubilitySCHERING PLOUGH ANIMAL HEALTH·Filed 2006·Granted Aug 11, 2009·8 cites·24 claims
- 4382US11286270B2Boronic acid derivatives and synthesis thereofQPEX BIOPHARMA INC·Filed 2018·Granted Mar 29, 2022·3 cites·69 claims
- 4482US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 4582US9084802B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2014·Granted Jul 21, 2015·3 cites·31 claims
- 4680US11684629B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2021·Granted Jun 27, 2023·0 cites·5 claims
- 4780US10239829B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·2 cites·20 claims
- 4880US6020121AInhibitors of regulatory pathwaysMICROCIDE PHARMACEUTICALS INC·Filed 1996·Granted Feb 1, 2000·67 cites·15 claims
- 4980US5789584ASubstituted-pyridinyl cephalosporin antibiotics active against methicillin resistant bacteriaMICROCIDE PHARMACEUTICALS INC·Filed 1995·Granted Aug 4, 1998·18 cites·11 claims
- 5079US9783494B2Glucagon antagonistsMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 10, 2017·3 cites·21 claims
Showing the top 50 of 100 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →